News Sentiment

ZVRA sentiment intelligence

Zevra Therapeutics Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 57 Balanced news tone 61 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 12.77 Week of 17 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-4.3% over one week, -1.0% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction -4.3% Price reacting lower
Trend fit Trend active -1.0% over four weeks
Fair value 64.2% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 20
Neutral 40
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
TradingView 10
Stock Titan 7
simplywall.st 5
GlobeNewswire 4
Finviz 3
www.marketscreener.com 3
Stock Traders Daily 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 21
Balance sheet 3
Analyst action 3
Regulatory and legal 2
Macro sensitivity 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 61